DIA Biosimilars 2013

Articles Published in 2011

Acceleron raises $30 million in private financing

Friday, December 23, 2011 10:32 AM

Acceleron Pharma has raised a $30M private financing. Celgene, one of Acceleron’s strategic partners, and all other existing investors participated in this financing. The proceeds will be used to expand and advance Acceleron’s clinical stage pipeline and to continue to support its highly productive research engine.

More... »

Cenduit: Now with Patient Reminders

AMRI to reduce U.S. workforce

Friday, December 23, 2011 10:17 AM

AMRI will reduce the company's workforce, right size capacity, and reduce operating costs in 2012. The actions will better align the business to current and expected market conditions and are expected to improve the company's overall cost competitiveness and increase cash flow generation.

More... »

CRF Health – eCOA Forum

Inspiration Biopharmaceuticals moves headquarters to Cambridge, MA

Thursday, December 22, 2011 01:35 PM
Inspiration Biopharmaceuticals will relocate its corporate headquarters to Cambridge, MA from Laguna Niguel, CA. The move is integral to Inspiration's plan to accommodate its anticipated future staffing and facility needs as the company transitions to product commercialization.

More... »

Medco shareholders approve merger with Express Scripts

Thursday, December 22, 2011 12:48 PM
Shareholders of Medco Health Solutions have approved a proposed merger with Express Scripts.

More... »

Intarcia, Quintiles form strategic partnership

Thursday, December 22, 2011 12:38 PM
Intarcia Therapeutics and Quintiles have signed definitive agreements whereby Quintiles will become a financial and strategic partner for the global clinical development of Intarcia’s ITCA 650.

More... »

ISPE names Berg president and CEO

Thursday, December 22, 2011 12:28 PM

ISPE, the International Society for Pharmaceutical Engineering, has named Nancy S. Berg president and CEO, effective January 1, 2012.

More... »

Delcath names Gores to medical advisory board

Thursday, December 22, 2011 11:57 AM
Delcath Systems has named Gregory Gores, M.D. to the company's medical advisory board.

More... »

Roese joins Marken

Thursday, December 22, 2011 11:29 AM
Marken has named Steve Roese vice president of its global quality assurance organization, which will support Marken's continued investment in their expanding network of pharmaceutical service depots around the world.

More... »

FDA, ABIA collaborate on safety and performance of materials in medical devices

Thursday, December 22, 2011 11:05 AM
Austen BioInnovation Institute in Akron (ABIA) and the FDA have entered into a collaboration to support and develop regulatory science for the safe and effective use of biomaterials in medical devices.

More... »

Report: Over one third of clinical trials are outsourced by pharma companies

Thursday, December 22, 2011 10:35 AM
Pharmaceutical companies are outsourcing drug research more frequently, and when they do they are handing off larger portions of the operation than ever before, reports Kalorama Information.

More... »

`
CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs